Company: GVH
Filing Date: 2025-04-15
Form Type: DRS
Source: 0001641172-25-004806
Chunk: 7

Company: Globavend Holdings Ltd
Filing Date: 2025-04-15
Form: DRS
Chunk 7
---
 to effect a Reserve Stock Spilt. We cannot assure you that our shareholders will
approve such Reverse Stock Split. See “The Offering – Nasdaq Deficiency Notice” and “Risk Factors – Risks related to our Ordinary Shares – We have received a deficiency letter from Nasdaq relating to our non-compliance with Nasdaq’s continued listing requirements and our Ordinary Shares could become subject to delisting from Nasdaq if we fail to regain compliance.” in our Annual Report on Form 20-F (the “Annual Report”) incorporated by reference in this
prospectus.

Investors are cautioned that you are buying shares of a Cayman Islands holding company with operations in Hong Kong by its operating subsidiary.

Globavend
Holdings is a holding company incorporated in the Cayman Islands with no material operations of its own, and we conduct our operations
primarily in Hong Kong through our HK Subsidiaries (as defined below). References to the “Company,” “we,”
“us,” and “our” in the prospectus are to Globavend Holdings, the Cayman Islands entity that will issue the Ordinary
Shares being offered. References to “Globavend HK” is to Globavend (HK) Limited, our operating subsidiary as of the
date of this prospectus. This is an offering of the Ordinary Shares of Globavend Holdings, the holding company in the Cayman Islands,
instead of the shares of our HK Subsidiaries, including Globavend HK. Investors in this Offering may never directly hold any equity
interests in our HK Subsidiaries, including Globavend HK.

Investing in our Ordinary Shares is highly speculative and involves a high degree of risk. Before buying any shares, you should carefully read the discussion of material risks of investing in our Ordinary Shares in “Risk Factors” beginning on page [15] of this prospectus, as well as “Item 3. Key Information—D. Risk Factors” in our Annual Report and in other documents incorporated by reference into this prospectus.

Our operations are principally
located in Hong Kong, a special administrative region of the People’s Republic of China (“China” or the “PRC”),
with its own governmental and legal system that is independent from mainland China, including having its own distinct laws and regulations.
As of the date of this prospectus, we are not subject to the PRC government’s direct influence or discretion over the manner in
which we conduct our business activities outside of the PRC. However,